• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identification of potential SARS-CoV-2 M inhibitors integrating molecular docking and water thermodynamics.整合分子对接和水热动力学鉴定潜在 SARS-CoV-2 M 抑制剂。
J Biomol Struct Dyn. 2022 Jul;40(11):5079-5089. doi: 10.1080/07391102.2020.1867642. Epub 2021 Jan 8.
2
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.基于药物再利用的分子对接和动力学模拟预测 SARS-CoV-2 主要蛋白酶的潜在抑制剂的计算机预测。
J Infect Public Health. 2020 Sep;13(9):1210-1223. doi: 10.1016/j.jiph.2020.06.016. Epub 2020 Jun 16.
3
Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.鉴定 SARS-CoV-2 主蛋白酶的高亲和力抑制剂:迈向有效的 COVID-19 治疗。
Virus Res. 2020 Oct 15;288:198102. doi: 10.1016/j.virusres.2020.198102. Epub 2020 Jul 24.
4
Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M.基于结构的虚拟筛选、计算机对接、ADME 性质预测和分子动力学研究,以鉴定针对 SARS-CoV-2 M 的潜在抑制剂。
Mol Divers. 2022 Jun;26(3):1645-1661. doi: 10.1007/s11030-021-10298-0. Epub 2021 Sep 4.
5
Exploring epigenetic drugs as potential inhibitors of SARS-CoV-2 main protease: a docking and MD simulation study.探讨表观遗传药物作为 SARS-CoV-2 主蛋白酶潜在抑制剂的研究:对接和 MD 模拟研究。
J Biomol Struct Dyn. 2024 Aug;42(13):6892-6903. doi: 10.1080/07391102.2023.2236714. Epub 2023 Jul 17.
6
Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (M) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation.计算真菌代谢产物 Pyranonigrin A 作为一种新型 SARS-CoV-2 病毒主要蛋白酶(M)抑制剂的潜力,该病毒是使用对接和分子动力学模拟发现的。
Biophys Chem. 2020 Sep;264:106425. doi: 10.1016/j.bpc.2020.106425. Epub 2020 Jul 6.
7
Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.合成类黄酮作为抗 SARS-CoV-2 主蛋白酶的潜在抗病毒药物。
J Biomol Struct Dyn. 2022 May;40(8):3777-3788. doi: 10.1080/07391102.2020.1850359. Epub 2020 Nov 30.
8
In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection.计算机模拟揭示 SARS-CoV-2 主要蛋白酶,提示 NADH 内源性防御在控制大流行冠状病毒感染中的作用。
Viruses. 2020 Jul 26;12(8):805. doi: 10.3390/v12080805.
9
Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies.通过虚拟筛选、ADMET 和分子动力学模拟研究发现针对 SARS-CoV-2 主蛋白酶的有效抑制剂。
J Biomol Struct Dyn. 2022 Sep;40(14):6556-6568. doi: 10.1080/07391102.2021.1897680. Epub 2021 Mar 8.
10
Molecular docking and simulation studies of natural compounds of L. against papain-like protease (PL) of SARS CoV-2 (coronavirus) to conquer the pandemic situation in the world.基于分子对接和模拟研究,探讨了 L. 的天然化合物对 SARS CoV-2(冠状病毒)木瓜蛋白酶样蛋白酶(PL)的抑制作用,以期攻克当前世界范围内的大流行病局势。
J Biomol Struct Dyn. 2022 Aug;40(12):5665-5686. doi: 10.1080/07391102.2021.1873185. Epub 2021 Jan 18.

引用本文的文献

1
Exploring target selectivity in designing and identifying PI3Kα inhibitors for triple negative breast cancer with fragment-based and bioisosteric replacement approach.采用基于片段和生物电子等排体替换方法设计和鉴定三阴性乳腺癌PI3Kα抑制剂时探索靶点选择性
Sci Rep. 2025 Jan 13;15(1):1890. doi: 10.1038/s41598-024-83030-1.
2
In Silico Analysis of Protein-Protein Interactions of Putative Endoplasmic Reticulum Metallopeptidase 1 in .内质网金属肽酶1假定蛋白-蛋白相互作用的计算机模拟分析
Curr Issues Mol Biol. 2024 May 12;46(5):4609-4629. doi: 10.3390/cimb46050280.
3
Synthesis and Biological Evaluation of Benzothiazolyl-pyridine Hybrids as New Antiviral Agents against H5N1 Bird Flu and SARS-COV-2 Viruses.苯并噻唑基吡啶杂合物作为抗H5N1禽流感和SARS-CoV-2病毒新型抗病毒药物的合成及生物学评价
ACS Omega. 2023 Sep 25;8(40):36636-36654. doi: 10.1021/acsomega.3c01987. eCollection 2023 Oct 10.
4
Antcin-B, a phytosterol-like compound from Taiwanofungus camphoratus inhibits SARS-CoV-2 3-chymotrypsin-like protease (3CL) activity in silico and in vitro.来自樟芝的植物固醇类似化合物 Antcin-B 通过计算机模拟和体外实验抑制 SARS-CoV-2 3 号半胱氨酸蛋白酶(3CL)活性。
Sci Rep. 2023 Oct 10;13(1):17106. doi: 10.1038/s41598-023-44476-x.
5
Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings.基于配体的冠状病毒主蛋白酶抑制剂的发现使用 MACAW 分子嵌入。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):24-35. doi: 10.1080/14756366.2022.2132486.
6
Pyrazolone-type compounds: synthesis and assessment of antiviral potential against key viral proteins of SARS-CoV-2.吡唑啉酮类化合物:针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关键病毒蛋白的合成及抗病毒潜力评估
RSC Adv. 2022 May 27;12(25):16054-16070. doi: 10.1039/d2ra02542f. eCollection 2022 May 23.

本文引用的文献

1
First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients.首个使用丙肝病毒蛋白酶抑制剂达诺普韦治疗新冠肺炎患者的临床研究。
Medicine (Baltimore). 2020 Nov 25;99(48):e23357. doi: 10.1097/MD.0000000000023357.
2
Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease.埃布斯硒啉与 SARS-CoV-2 主蛋白酶结合活性的分子特征。
Sci Adv. 2020 Sep 11;6(37). doi: 10.1126/sciadv.abd0345. Print 2020 Sep.
3
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.博赛泼维与 GC376 均可通过靶向作用于 SARS-CoV-2 的主蛋白酶而有效抑制该病毒。
Nat Commun. 2020 Sep 4;11(1):4417. doi: 10.1038/s41467-020-18233-x.
4
Reply to: "Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19".回复:“达芦那韦/考比司他治疗COVID-19的抗病毒活性及安全性”
Open Forum Infect Dis. 2020 Jul 29;7(8):ofaa321. doi: 10.1093/ofid/ofaa321. eCollection 2020 Aug.
5
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial.洛匹那韦/利托那韦或阿比多尔治疗成人轻/中度 COVID-19 患者的疗效和安全性:一项探索性随机对照试验。
Med. 2020 Dec 18;1(1):105-113.e4. doi: 10.1016/j.medj.2020.04.001. Epub 2020 May 19.
6
Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2.与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)靶点跨膜丝氨酸蛋白酶2(TMPRSS2)结合的实验性药物的结构分析
J Mol Graph Model. 2020 Nov;100:107710. doi: 10.1016/j.jmgm.2020.107710. Epub 2020 Aug 11.
7
Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?针对冠状病毒感染的疫苗候选者。COVID-19 处于什么位置?
Viruses. 2020 Aug 7;12(8):861. doi: 10.3390/v12080861.
8
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.阿维福韦治疗中度 2019 冠状病毒病(COVID-19)患者:一项 II/III 期多中心随机临床试验的中期结果。
Clin Infect Dis. 2021 Aug 2;73(3):531-534. doi: 10.1093/cid/ciaa1176.
9
The SARS-CoV-2 main protease as drug target.SARS-CoV-2 主要蛋白酶作为药物靶点。
Bioorg Med Chem Lett. 2020 Sep 1;30(17):127377. doi: 10.1016/j.bmcl.2020.127377. Epub 2020 Jul 2.
10
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.针对 SARS-CoV-2 刺突蛋白多个表位的强效中和抗体。
Nature. 2020 Aug;584(7821):450-456. doi: 10.1038/s41586-020-2571-7. Epub 2020 Jul 22.

整合分子对接和水热动力学鉴定潜在 SARS-CoV-2 M 抑制剂。

Identification of potential SARS-CoV-2 M inhibitors integrating molecular docking and water thermodynamics.

机构信息

National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, Punjab, India.

出版信息

J Biomol Struct Dyn. 2022 Jul;40(11):5079-5089. doi: 10.1080/07391102.2020.1867642. Epub 2021 Jan 8.

DOI:10.1080/07391102.2020.1867642
PMID:33413032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7876914/
Abstract

The COVID-19 pandemic is an ongoing global health emergency caused by a newly discovered coronavirus SARS-CoV-2. The entire scientific community across the globe is working diligently to tackle this unprecedented challenge. studies have played a crucial role in the current situation by expediting the process of identification of novel potential chemotypes targeting the viral receptors. In this study, we have made efforts to identify molecules that can potentially inhibit the SARS-CoV-2 main protease (M) using the high-resolution crystal structure of SARS-CoV-2 M. The SARS-CoV-2 M has a large flexible binding pocket that can accommodate various chemically diverse ligands but a complete occupation of the binding cavity is necessary for efficient inhibition and stability. We augmented glide three-tier molecular docking protocol with water thermodynamics to screen molecules obtained from three different compound libraries. The diverse hits obtained through docking studies were scored against generated WaterMap to enrich the quality of results. Five molecules were selected from each compound library on the basis of scores and protein-ligand complementarity. Further MD simulations on the proposed molecules affirm the stability of these molecules in the complex. MM-GBSA results and intermolecular hydrogen bond analysis also confirm the thermodynamic stability of proposed molecules. This study also presumably steers the structure determination of many ligand-main protease complexes using x-ray diffraction methods.Communicated by Ramaswamy H. Sarma.

摘要

新型冠状病毒(SARS-CoV-2)引发的 COVID-19 大流行是一场持续的全球卫生紧急事件。全球整个科学界正在努力应对这一前所未有的挑战。研究在当前形势中发挥了关键作用,加速了识别针对病毒受体的新型潜在化学型的过程。在这项研究中,我们利用 SARS-CoV-2 M 的高分辨率晶体结构,努力寻找可能抑制 SARS-CoV-2 主要蛋白酶(M)的分子。SARS-CoV-2 M 有一个大的灵活结合口袋,可以容纳各种化学上不同的配体,但完全占据结合腔对于有效的抑制和稳定性是必要的。我们用水热力学增强了 Glide 三阶梯分子对接方案,筛选来自三个不同化合物库的分子。通过对接研究获得的多样命中物根据生成的 WaterMap 进行评分,以丰富结果的质量。根据得分和蛋白-配体互补性,从每个化合物库中选择了 5 个分子。对提出的分子进行进一步的 MD 模拟,确认了这些分子在复合物中的稳定性。MM-GBSA 结果和分子间氢键分析也证实了提出的分子的热力学稳定性。这项研究也可能指导使用 X 射线衍射方法确定许多配体-主蛋白酶复合物的结构。Ramashwamy H. Sarma 通讯。